Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Coronary Pressure Monitors Market Trends

ID: MRFR/MED/3342-CR
90 Pages
Vikita Thakur
Last Updated: March 28, 2026

Coronary Pressure Monitors Market Research Report Information By Device (Sphygmomanometer, Automated Blood Pressure Monitor, BP Transducers, and Ambulatory Blood Pressure Monitor), By End User (Hospitals & Clinics, Home Healthcare, and Others), and Region (North America, Europe, Asia-Pacific, and the Rest of the World)—Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Coronary Pressure Monitors Market Infographic
Purchase Options

Market Trends

Key Emerging Trends in the Coronary Pressure Monitors Market

The coronary pressure monitors market is a basic part of cardiovascular healthcare, focusing in on gadgets used to quantify pressures inside the coronary veins. As a fundamental device in diagnosing and overseeing coronary corridor diseases, market patterns are molded by mechanical developments, expanding ubiquity of cardiovascular circumstances, and a developing emphasis on precision medicine. The market is impacted by the worldwide ascent in cardiovascular diseases, including coronary course diseases. The rising predominance of conditions, for example, angina and myocardial infarction drives the interest for coronary pressure monitors as fundamental demonstrative devices in cardiology. The joining of Fractional Flow Reserve (FFR) technologies is an outstanding pattern in the market. FFR-directed mediations give real-time evaluations of blood flow in the coronary conduits, supporting doctors in settling on educated conclusions about the necessity regarding intercessions like stent preparation. The market is seeing a shift towards non-invasive coronary pressure observing procedures. Non-invasive strategies, including CT angiography-based FFR, offer patients a less invasive other option, adding to worked on patient solace and Coronary pressure monitors are progressively embraced in interventional cardiology systems. The real-time pressure estimations help cardiologists in enhancing stent arrangement, directing angioplasty techniques, and going with informed choices during coronary mediations. The market sees growing applications in research and clinical preliminaries connected with cardiovascular diseases. Coronary pressure monitors are instrumental in concentrating on the viability of new medicines, surveying the results of mediations, and contributing significant data to progress cardiovascular examination. The globalization of healthcare adds to market patterns, as cutting edge coronary pressure observing technologies become all the more generally open. This pattern guarantees that patients all over the planet approach best in class symptomatic devices, at last working on the standard of care. The joining of telemedicine and remote observing highlights in coronary pressure monitors is arising as a pattern. These elements empower healthcare experts to screen patients' cardiovascular health from a distance, upgrading the consistency of care and working with timely mediations.

Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Leave a Comment

FAQs

What is the projected market valuation for The Global Coronary Pressure Monitors in 2035?

<p>The projected market valuation for The Global Coronary Pressure Monitors in 2035 is 58.75 USD Billion.</p>

What was the overall market valuation for The Global Coronary Pressure Monitors in 2024?

<p>The overall market valuation for The Global Coronary Pressure Monitors in 2024 was 32.6 USD Billion.</p>

What is the expected CAGR for The Global Coronary Pressure Monitors during the forecast period 2025 - 2035?

<p>The expected CAGR for The Global Coronary Pressure Monitors during the forecast period 2025 - 2035 is 5.5%.</p>

Which companies are considered key players in The Global Coronary Pressure Monitors?

<p>Key players in The Global Coronary Pressure Monitors include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, and Philips Healthcare.</p>

What are the projected valuations for Sphygmomanometers in The Global Coronary Pressure Monitors by 2035?

<p>The projected valuation for Sphygmomanometers in The Global Coronary Pressure Monitors is expected to reach 14.5 USD Billion by 2035.</p>

How much is the Automated Blood Pressure Monitor segment expected to grow by 2035?

<p>The Automated Blood Pressure Monitor segment is projected to grow to 18.0 USD Billion by 2035.</p>

What is the anticipated market size for BP Transducers in 2035?

The anticipated market size for BP Transducers in 2035 is expected to be 12.0 USD Billion.

What is the projected market size for Home Healthcare in The Global Coronary Pressure Monitors by 2035?

The projected market size for Home Healthcare in The Global Coronary Pressure Monitors is expected to reach 18.0 USD Billion by 2035.

What segment is expected to have the highest valuation in The Global Coronary Pressure Monitors by 2035?

The Hospitals &amp; Clinics segment is expected to have the highest valuation, reaching 23.0 USD Billion by 2035.

What is the expected growth trajectory for the Others segment in The Global Coronary Pressure Monitors?

The Others segment is projected to grow to 17.75 USD Billion by 2035.

Market Summary

As per Market Research Future analysis, The Global Coronary Pressure Monitors Market was estimated at 32.6 USD Billion in 2024. The market is projected to grow from 34.39 USD Billion in 2025 to 58.75 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Global Coronary Pressure Monitors Market is poised for substantial growth driven by technological advancements and increasing healthcare awareness.

  • Technological advancements are enhancing the accuracy and efficiency of coronary pressure monitors, particularly in North America.
  • The rising incidence of cardiovascular diseases is propelling demand for automated blood pressure monitors, which remain the largest segment.
  • Asia-Pacific is emerging as the fastest-growing region, driven by increasing investments in healthcare infrastructure and preventive care.
  • Market drivers such as regulatory support and the growing awareness of heart health are significantly influencing the expansion of home healthcare solutions.

Market Size & Forecast

2024 Market Size 32.6 (USD Billion)
2035 Market Size 58.75 (USD Billion)
CAGR (2025 - 2035) 5.5%
Largest Regional Market Share in 2024 North America

Major Players

Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cardinal Health, Inc. (US)

Market Trends

The Global Coronary Pressure Monitors Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing emphasis on patient-centered care. The integration of innovative features, such as wireless connectivity and real-time monitoring capabilities, appears to enhance the functionality of these devices. Furthermore, the growing prevalence of cardiovascular diseases worldwide necessitates the adoption of effective monitoring solutions, which may lead to a surge in demand for coronary pressure monitors. As healthcare systems strive to improve patient outcomes, the focus on precision medicine and personalized treatment plans is likely to further propel market growth. In addition, regulatory bodies are increasingly recognizing the importance of coronary pressure monitoring in clinical settings. This recognition may result in the establishment of more stringent guidelines and standards, which could influence the design and manufacturing processes of these devices. Moreover, the rising awareness among healthcare professionals regarding the benefits of continuous monitoring is expected to foster a more favorable environment for The Global Coronary Pressure Monitors Market. As the market continues to evolve, stakeholders must remain vigilant to emerging trends and adapt their strategies accordingly to maintain a competitive edge.

Technological Advancements

The Global Coronary Pressure Monitors Market is witnessing rapid technological advancements, particularly in the areas of sensor technology and data analytics. These innovations are likely to enhance the accuracy and reliability of pressure measurements, thereby improving patient outcomes.

Increased Focus on Preventive Healthcare

There is a growing emphasis on preventive healthcare, which may drive the demand for coronary pressure monitors. Healthcare providers are increasingly prioritizing early detection and management of cardiovascular conditions, leading to a higher adoption rate of monitoring devices.

Regulatory Developments

Regulatory bodies are expected to implement more comprehensive guidelines for coronary pressure monitoring devices. These developments could influence market dynamics by ensuring higher safety and efficacy standards, thereby fostering consumer trust.

Coronary Pressure Monitors Market Market Drivers

Regulatory Support and Standardization

Regulatory support and the establishment of standardized protocols for coronary pressure monitoring are emerging as crucial drivers for the Coronary Pressure Monitors Market. Regulatory bodies are increasingly recognizing the importance of these devices in managing cardiovascular health, leading to streamlined approval processes and enhanced market access. The introduction of guidelines that promote the use of coronary pressure monitors in clinical practice may further stimulate demand. Additionally, standardization efforts aimed at ensuring the accuracy and reliability of these devices could enhance consumer confidence and adoption rates. As regulatory frameworks evolve, they are likely to create a conducive environment for market growth, encouraging manufacturers to innovate and expand their product offerings.

Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare strategies is likely to significantly influence the Coronary Pressure Monitors Market. Healthcare systems worldwide are increasingly prioritizing early detection and management of cardiovascular conditions to reduce long-term healthcare costs. This shift towards preventive measures encourages the adoption of coronary pressure monitors, as they enable healthcare professionals to identify potential issues before they escalate. Market data indicates that investments in preventive healthcare initiatives have surged, with many countries allocating substantial budgets to enhance screening and monitoring programs. This trend suggests a favorable environment for the growth of the coronary pressure monitors market, as healthcare providers seek to integrate these devices into routine check-ups and health assessments.

Rising Incidence of Cardiovascular Diseases

The escalating prevalence of cardiovascular diseases globally serves as a significant driver for the Coronary Pressure Monitors Market. According to recent health statistics, cardiovascular diseases account for a substantial proportion of global mortality rates, necessitating effective monitoring solutions. The increasing number of patients requiring regular monitoring of coronary pressure is likely to boost the demand for these devices. Furthermore, the aging population, which is more susceptible to heart-related ailments, contributes to this rising trend. It is estimated that by 2030, the number of individuals aged 60 and above will reach 1.4 billion, further intensifying the need for reliable monitoring solutions. Consequently, this growing patient demographic is expected to drive market expansion, as healthcare providers seek to implement advanced monitoring technologies.

Growing Awareness and Education on Heart Health

The rising awareness and education regarding heart health among the general population appear to be a significant driver for the Coronary Pressure Monitors Market. Public health campaigns and educational initiatives aimed at promoting cardiovascular health are increasingly prevalent, leading to a more informed consumer base. This heightened awareness encourages individuals to seek regular monitoring of their heart health, thereby driving demand for coronary pressure monitors. Market Research Future indicates that consumers are becoming more proactive in managing their health, with many individuals now prioritizing regular check-ups and monitoring. This trend suggests a potential increase in the adoption of coronary pressure monitors, as individuals recognize the importance of early detection and management of cardiovascular issues.

Technological Advancements in Monitoring Devices

The emergence of advanced technologies in the field of medical devices appears to be a pivotal driver for the Coronary Pressure Monitors Market. Innovations such as wireless connectivity, real-time data analytics, and miniaturization of devices enhance the functionality and usability of coronary pressure monitors. These advancements facilitate remote patient monitoring, which is increasingly favored in contemporary healthcare settings. The integration of artificial intelligence and machine learning algorithms into these devices may further improve diagnostic accuracy and patient outcomes. As a result, the market is projected to witness substantial growth, with estimates suggesting a compound annual growth rate of over 8% in the coming years. This trend indicates a robust demand for technologically advanced coronary pressure monitors, thereby propelling the market forward.

Market Segment Insights

By Device: Automated Blood Pressure Monitor (Largest) vs. Ambulatory Blood Pressure Monitor (Fastest-Growing)

In The Global Coronary Pressure Monitors Market, the device segment is primarily dominated by Automated Blood Pressure Monitors, which command a significant share due to their ease of use and adoption in both clinical and home settings. Following closely are Sphygmomanometers, which retain their relevance in traditional settings. BP Transducers hold a smaller share but are critical for real-time monitoring in hospital environments, while Ambulatory Blood Pressure Monitors are carving a niche as they grow rapidly in response to increasing needs for at-home health monitoring. Growth trends in this segment indicate a shift towards more automated and smart devices, driven by rising awareness of cardiovascular diseases and the need for continuous monitoring. The increasing prevalence of hypertension and lifestyle-related conditions propels demand for devices that offer accurate readings, ease of use, and integrated technology. Future innovations in wireless monitoring, connectivity, and data analytics are likely to further propel this segment's growth, with Ambulatory Blood Pressure Monitors leading the charge as a fast-growing category.

Automated Blood Pressure Monitor (Dominant) vs. Ambulatory Blood Pressure Monitor (Emerging)

Automated Blood Pressure Monitors are the dominant players in the coronary pressure monitors market, primarily due to their high accuracy, user-friendliness, and ability to store multiple readings. These devices are commonly used both in medical facilities and by patients at home, making them versatile tools in the management of cardiovascular health. In contrast, Ambulatory Blood Pressure Monitors, which are designed for continuous monitoring over a period, have emerged as a rapidly growing segment. They provide 24-hour blood pressure readings, which help in diagnosing conditions like white coat hypertension. As healthcare trends lean towards preventative measures and remote monitoring, both segments are positioned to thrive, supporting better patient outcomes.

By End User: Hospitals & Clinics (Largest) vs. Home Healthcare (Fastest-Growing)

In The Global Coronary Pressure Monitors Market, the end user segment is primarily dominated by Hospitals & Clinics, which encompass a significant share of the market. These institutions leverage advanced coronary pressure monitoring technologies to enhance patient care and management. On the other hand, <a href="https://www.marketresearchfuture.com/reports/home-healthcare-market-2030" target="_blank" title="home healthcare">Home Healthcare</a> is rapidly gaining ground, reflecting a shift towards patient-centric care that allows for monitoring in a comfortable home environment, indicating a growing acceptance of these devices outside traditional medical settings.

Hospitals & Clinics (Dominant) vs. Home Healthcare (Emerging)

Hospitals & Clinics serve as the dominant end users in The Global Coronary Pressure Monitors Market due to their access to comprehensive healthcare resources and a continuous influx of patients requiring cardiac monitoring. The advanced infrastructure and specialized medical staff at these facilities enable better patient management and accurate diagnostics. Conversely, Home Healthcare represents the emerging segment, driven by increased consumer demand for convenience and the proliferation of telehealth services. Patients now prefer monitoring their cardiac health from home, aided by technological advancements that ensure data reliability and connectivity to healthcare providers, thus fostering a proactive approach to health management.

Get more detailed insights about Coronary Pressure Monitors Market Research Report – Global Forecast Till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for coronary pressure monitors, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovative medical technologies. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The United States is the primary contributor, with significant investments from key players such as Abbott Laboratories and Boston Scientific Corporation. The competitive landscape is characterized by rapid technological advancements and a robust pipeline of new products. Canada also plays a vital role, contributing to the market with its growing healthcare expenditure and increasing adoption of advanced monitoring systems.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for coronary pressure monitors, accounting for around 30% of the global market share. The region benefits from stringent regulatory frameworks that ensure high-quality medical devices, fostering consumer trust and driving demand. The increasing incidence of heart diseases and an aging population are significant growth drivers, alongside initiatives aimed at improving healthcare access and quality across member states. Leading countries include Germany, France, and the UK, where major players like Siemens Healthineers and Philips Healthcare are actively innovating. The competitive landscape is marked by collaborations and partnerships aimed at enhancing product offerings. The European market is also witnessing a rise in telemedicine, further boosting the demand for advanced monitoring solutions.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is witnessing rapid growth in the coronary pressure monitors market, holding approximately 20% of the global share. The region's expansion is fueled by increasing healthcare investments, rising awareness of cardiovascular health, and a growing elderly population. Countries like China and India are leading this growth, supported by government initiatives aimed at enhancing healthcare infrastructure and access to advanced medical technologies. China stands out as a key player, with significant contributions from local manufacturers and international companies like Medtronic and GE Healthcare. The competitive landscape is evolving, with a focus on affordability and accessibility of medical devices. Additionally, the region is experiencing a surge in telehealth services, which is expected to further drive the demand for coronary pressure monitors.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the coronary pressure monitors market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising prevalence of cardiovascular diseases, and a focus on improving healthcare infrastructure. Governments are implementing policies to enhance healthcare access, which is expected to boost demand for advanced medical devices in the coming years. Countries like South Africa and the UAE are leading the market, with a growing presence of international players. The competitive landscape is characterized by partnerships and collaborations aimed at enhancing product availability. As healthcare systems evolve, the demand for coronary pressure monitors is anticipated to rise, presenting significant opportunities for market players.

Key Players and Competitive Insights

The Global Coronary Pressure Monitors is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing emphasis on patient-centric healthcare solutions. Key players such as Abbott Laboratories (US), Boston Scientific Corporation (US), and Medtronic plc (IE) are at the forefront, each adopting distinct strategies to enhance their market positioning. Abbott Laboratories (US) focuses on innovation, particularly in developing advanced pressure monitoring systems that integrate seamlessly with digital health platforms. Meanwhile, Boston Scientific Corporation (US) emphasizes strategic partnerships to expand its product offerings and enhance its market reach. Medtronic plc (IE) is actively pursuing regional expansion, particularly in emerging markets, to capitalize on the growing demand for coronary pressure monitoring solutions.

The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure appears moderately fragmented, with several players vying for market share, yet the collective influence of these key companies is substantial. Their strategies not only enhance their competitive edge but also contribute to shaping the overall market dynamics, fostering an environment where innovation and operational efficiency are paramount.

In August 2025, Abbott Laboratories (US) announced the launch of a new coronary pressure monitoring device that utilizes advanced sensor technology to provide real-time data analytics. This strategic move is significant as it positions Abbott at the cutting edge of digital health integration, potentially improving patient outcomes and streamlining clinical workflows. The introduction of such innovative products is likely to enhance Abbott's competitive advantage in a market that increasingly values technological sophistication.

In September 2025, Boston Scientific Corporation (US) entered into a collaboration with a leading telehealth provider to enhance remote monitoring capabilities for coronary pressure devices. This partnership is indicative of a broader trend towards digital health solutions, suggesting that Boston Scientific is keen on leveraging technology to improve patient engagement and adherence to treatment protocols. Such strategic alliances may prove crucial in differentiating their offerings in a crowded marketplace.

In July 2025, Medtronic plc (IE) expanded its manufacturing capabilities in Asia, aiming to meet the rising demand for coronary pressure monitors in the region. This expansion not only reflects Medtronic's commitment to regional growth but also underscores the importance of supply chain optimization in maintaining competitive pricing and availability. By localizing production, Medtronic is likely to enhance its responsiveness to market needs while reducing operational costs.

As of October 2025, the competitive trends within The Global Coronary Pressure Monitors are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to deliver comprehensive, patient-centered solutions.

Key Companies in the Coronary Pressure Monitors Market include

Industry Developments

Future Outlook

Coronary Pressure Monitors Market Future Outlook

The Global Coronary Pressure Monitors Market is projected to grow at a 5.5% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of portable coronary pressure monitoring devices for home use.
  • Integration of AI analytics for real-time patient monitoring and data interpretation.
  • Expansion into emerging markets with tailored pricing strategies and local partnerships.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic market positioning.

Market Segmentation

Coronary Pressure Monitors Market Device Outlook

  • Sphygmomanometer
  • Automated Blood Pressure Monitor
  • BP Transducers
  • Ambulatory Blood Pressure Monitor

Coronary Pressure Monitors Market End User Outlook

  • Hospitals & Clinics
  • Home Healthcare
  • Others

Report Scope

MARKET SIZE 2024 32.6(USD Billion)
MARKET SIZE 2025 34.39(USD Billion)
MARKET SIZE 2035 58.75(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott Laboratories (US), Boston Scientific Corporation (US), Medtronic plc (IE), Philips Healthcare (NL), Siemens Healthineers (DE), GE Healthcare (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cardinal Health, Inc. (US)
Segments Covered Device, End User
Key Market Opportunities Integration of advanced analytics and artificial intelligence in The Global Coronary Pressure Monitors enhances diagnostic accuracy.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the coronary pressure monitors market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation for The Global Coronary Pressure Monitors in 2035?

<p>The projected market valuation for The Global Coronary Pressure Monitors in 2035 is 58.75 USD Billion.</p>

What was the overall market valuation for The Global Coronary Pressure Monitors in 2024?

<p>The overall market valuation for The Global Coronary Pressure Monitors in 2024 was 32.6 USD Billion.</p>

What is the expected CAGR for The Global Coronary Pressure Monitors during the forecast period 2025 - 2035?

<p>The expected CAGR for The Global Coronary Pressure Monitors during the forecast period 2025 - 2035 is 5.5%.</p>

Which companies are considered key players in The Global Coronary Pressure Monitors?

<p>Key players in The Global Coronary Pressure Monitors include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, and Philips Healthcare.</p>

What are the projected valuations for Sphygmomanometers in The Global Coronary Pressure Monitors by 2035?

<p>The projected valuation for Sphygmomanometers in The Global Coronary Pressure Monitors is expected to reach 14.5 USD Billion by 2035.</p>

How much is the Automated Blood Pressure Monitor segment expected to grow by 2035?

<p>The Automated Blood Pressure Monitor segment is projected to grow to 18.0 USD Billion by 2035.</p>

What is the anticipated market size for BP Transducers in 2035?

The anticipated market size for BP Transducers in 2035 is expected to be 12.0 USD Billion.

What is the projected market size for Home Healthcare in The Global Coronary Pressure Monitors by 2035?

The projected market size for Home Healthcare in The Global Coronary Pressure Monitors is expected to reach 18.0 USD Billion by 2035.

What segment is expected to have the highest valuation in The Global Coronary Pressure Monitors by 2035?

The Hospitals &amp; Clinics segment is expected to have the highest valuation, reaching 23.0 USD Billion by 2035.

What is the expected growth trajectory for the Others segment in The Global Coronary Pressure Monitors?

The Others segment is projected to grow to 17.75 USD Billion by 2035.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Device (USD Billion)
    2. | | 4.1.1 Sphygmomanometer
    3. | | 4.1.2 Automated Blood Pressure Monitor
    4. | | 4.1.3 BP Transducers
    5. | | 4.1.4 Ambulatory Blood Pressure Monitor
    6. | 4.2 Healthcare, BY End User (USD Billion)
    7. | | 4.2.1 Hospitals & Clinics
    8. | | 4.2.2 Home Healthcare
    9. | | 4.2.3 Others
    10. | 4.3 Healthcare, BY Region (USD Billion)
    11. | | 4.3.1 North America
    12. | | | 4.3.1.1 US
    13. | | | 4.3.1.2 Canada
    14. | | 4.3.2 Europe
    15. | | | 4.3.2.1 Germany
    16. | | | 4.3.2.2 UK
    17. | | | 4.3.2.3 France
    18. | | | 4.3.2.4 Russia
    19. | | | 4.3.2.5 Italy
    20. | | | 4.3.2.6 Spain
    21. | | | 4.3.2.7 Rest of Europe
    22. | | 4.3.3 APAC
    23. | | | 4.3.3.1 China
    24. | | | 4.3.3.2 India
    25. | | | 4.3.3.3 Japan
    26. | | | 4.3.3.4 South Korea
    27. | | | 4.3.3.5 Malaysia
    28. | | | 4.3.3.6 Thailand
    29. | | | 4.3.3.7 Indonesia
    30. | | | 4.3.3.8 Rest of APAC
    31. | | 4.3.4 South America
    32. | | | 4.3.4.1 Brazil
    33. | | | 4.3.4.2 Mexico
    34. | | | 4.3.4.3 Argentina
    35. | | | 4.3.4.4 Rest of South America
    36. | | 4.3.5 MEA
    37. | | | 4.3.5.1 GCC Countries
    38. | | | 4.3.5.2 South Africa
    39. | | | 4.3.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott Laboratories (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Boston Scientific Corporation (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Medtronic plc (IE)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Philips Healthcare (NL)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Siemens Healthineers (DE)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 GE Healthcare (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Johnson & Johnson (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 B. Braun Melsungen AG (DE)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Cardinal Health, Inc. (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY DEVICE
    4. | 6.4 US MARKET ANALYSIS BY END USER
    5. | 6.5 CANADA MARKET ANALYSIS BY DEVICE
    6. | 6.6 CANADA MARKET ANALYSIS BY END USER
    7. | 6.7 EUROPE MARKET ANALYSIS
    8. | 6.8 GERMANY MARKET ANALYSIS BY DEVICE
    9. | 6.9 GERMANY MARKET ANALYSIS BY END USER
    10. | 6.10 UK MARKET ANALYSIS BY DEVICE
    11. | 6.11 UK MARKET ANALYSIS BY END USER
    12. | 6.12 FRANCE MARKET ANALYSIS BY DEVICE
    13. | 6.13 FRANCE MARKET ANALYSIS BY END USER
    14. | 6.14 RUSSIA MARKET ANALYSIS BY DEVICE
    15. | 6.15 RUSSIA MARKET ANALYSIS BY END USER
    16. | 6.16 ITALY MARKET ANALYSIS BY DEVICE
    17. | 6.17 ITALY MARKET ANALYSIS BY END USER
    18. | 6.18 SPAIN MARKET ANALYSIS BY DEVICE
    19. | 6.19 SPAIN MARKET ANALYSIS BY END USER
    20. | 6.20 REST OF EUROPE MARKET ANALYSIS BY DEVICE
    21. | 6.21 REST OF EUROPE MARKET ANALYSIS BY END USER
    22. | 6.22 APAC MARKET ANALYSIS
    23. | 6.23 CHINA MARKET ANALYSIS BY DEVICE
    24. | 6.24 CHINA MARKET ANALYSIS BY END USER
    25. | 6.25 INDIA MARKET ANALYSIS BY DEVICE
    26. | 6.26 INDIA MARKET ANALYSIS BY END USER
    27. | 6.27 JAPAN MARKET ANALYSIS BY DEVICE
    28. | 6.28 JAPAN MARKET ANALYSIS BY END USER
    29. | 6.29 SOUTH KOREA MARKET ANALYSIS BY DEVICE
    30. | 6.30 SOUTH KOREA MARKET ANALYSIS BY END USER
    31. | 6.31 MALAYSIA MARKET ANALYSIS BY DEVICE
    32. | 6.32 MALAYSIA MARKET ANALYSIS BY END USER
    33. | 6.33 THAILAND MARKET ANALYSIS BY DEVICE
    34. | 6.34 THAILAND MARKET ANALYSIS BY END USER
    35. | 6.35 INDONESIA MARKET ANALYSIS BY DEVICE
    36. | 6.36 INDONESIA MARKET ANALYSIS BY END USER
    37. | 6.37 REST OF APAC MARKET ANALYSIS BY DEVICE
    38. | 6.38 REST OF APAC MARKET ANALYSIS BY END USER
    39. | 6.39 SOUTH AMERICA MARKET ANALYSIS
    40. | 6.40 BRAZIL MARKET ANALYSIS BY DEVICE
    41. | 6.41 BRAZIL MARKET ANALYSIS BY END USER
    42. | 6.42 MEXICO MARKET ANALYSIS BY DEVICE
    43. | 6.43 MEXICO MARKET ANALYSIS BY END USER
    44. | 6.44 ARGENTINA MARKET ANALYSIS BY DEVICE
    45. | 6.45 ARGENTINA MARKET ANALYSIS BY END USER
    46. | 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE
    47. | 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    48. | 6.48 MEA MARKET ANALYSIS
    49. | 6.49 GCC COUNTRIES MARKET ANALYSIS BY DEVICE
    50. | 6.50 GCC COUNTRIES MARKET ANALYSIS BY END USER
    51. | 6.51 SOUTH AFRICA MARKET ANALYSIS BY DEVICE
    52. | 6.52 SOUTH AFRICA MARKET ANALYSIS BY END USER
    53. | 6.53 REST OF MEA MARKET ANALYSIS BY DEVICE
    54. | 6.54 REST OF MEA MARKET ANALYSIS BY END USER
    55. | 6.55 KEY BUYING CRITERIA OF HEALTHCARE
    56. | 6.56 RESEARCH PROCESS OF MRFR
    57. | 6.57 DRO ANALYSIS OF HEALTHCARE
    58. | 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. | 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. | 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
    61. | 6.61 HEALTHCARE, BY DEVICE, 2024 (% SHARE)
    62. | 6.62 HEALTHCARE, BY DEVICE, 2024 TO 2035 (USD Billion)
    63. | 6.63 HEALTHCARE, BY END USER, 2024 (% SHARE)
    64. | 6.64 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    65. | 6.65 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY DEVICE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USER, 2025-2035 (USD Billion)
    6. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    7. | | 7.3.1 BY DEVICE, 2025-2035 (USD Billion)
    8. | | 7.3.2 BY END USER, 2025-2035 (USD Billion)
    9. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.4.1 BY DEVICE, 2025-2035 (USD Billion)
    11. | | 7.4.2 BY END USER, 2025-2035 (USD Billion)
    12. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    13. | | 7.5.1 BY DEVICE, 2025-2035 (USD Billion)
    14. | | 7.5.2 BY END USER, 2025-2035 (USD Billion)
    15. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.6.1 BY DEVICE, 2025-2035 (USD Billion)
    17. | | 7.6.2 BY END USER, 2025-2035 (USD Billion)
    18. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.7.1 BY DEVICE, 2025-2035 (USD Billion)
    20. | | 7.7.2 BY END USER, 2025-2035 (USD Billion)
    21. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.8.1 BY DEVICE, 2025-2035 (USD Billion)
    23. | | 7.8.2 BY END USER, 2025-2035 (USD Billion)
    24. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    25. | | 7.9.1 BY DEVICE, 2025-2035 (USD Billion)
    26. | | 7.9.2 BY END USER, 2025-2035 (USD Billion)
    27. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.10.1 BY DEVICE, 2025-2035 (USD Billion)
    29. | | 7.10.2 BY END USER, 2025-2035 (USD Billion)
    30. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    31. | | 7.11.1 BY DEVICE, 2025-2035 (USD Billion)
    32. | | 7.11.2 BY END USER, 2025-2035 (USD Billion)
    33. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.12.1 BY DEVICE, 2025-2035 (USD Billion)
    35. | | 7.12.2 BY END USER, 2025-2035 (USD Billion)
    36. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    37. | | 7.13.1 BY DEVICE, 2025-2035 (USD Billion)
    38. | | 7.13.2 BY END USER, 2025-2035 (USD Billion)
    39. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.14.1 BY DEVICE, 2025-2035 (USD Billion)
    41. | | 7.14.2 BY END USER, 2025-2035 (USD Billion)
    42. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    43. | | 7.15.1 BY DEVICE, 2025-2035 (USD Billion)
    44. | | 7.15.2 BY END USER, 2025-2035 (USD Billion)
    45. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.16.1 BY DEVICE, 2025-2035 (USD Billion)
    47. | | 7.16.2 BY END USER, 2025-2035 (USD Billion)
    48. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.17.1 BY DEVICE, 2025-2035 (USD Billion)
    50. | | 7.17.2 BY END USER, 2025-2035 (USD Billion)
    51. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.18.1 BY DEVICE, 2025-2035 (USD Billion)
    53. | | 7.18.2 BY END USER, 2025-2035 (USD Billion)
    54. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    55. | | 7.19.1 BY DEVICE, 2025-2035 (USD Billion)
    56. | | 7.19.2 BY END USER, 2025-2035 (USD Billion)
    57. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.20.1 BY DEVICE, 2025-2035 (USD Billion)
    59. | | 7.20.2 BY END USER, 2025-2035 (USD Billion)
    60. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    61. | | 7.21.1 BY DEVICE, 2025-2035 (USD Billion)
    62. | | 7.21.2 BY END USER, 2025-2035 (USD Billion)
    63. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.22.1 BY DEVICE, 2025-2035 (USD Billion)
    65. | | 7.22.2 BY END USER, 2025-2035 (USD Billion)
    66. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    67. | | 7.23.1 BY DEVICE, 2025-2035 (USD Billion)
    68. | | 7.23.2 BY END USER, 2025-2035 (USD Billion)
    69. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.24.1 BY DEVICE, 2025-2035 (USD Billion)
    71. | | 7.24.2 BY END USER, 2025-2035 (USD Billion)
    72. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    73. | | 7.25.1 BY DEVICE, 2025-2035 (USD Billion)
    74. | | 7.25.2 BY END USER, 2025-2035 (USD Billion)
    75. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.26.1 BY DEVICE, 2025-2035 (USD Billion)
    77. | | 7.26.2 BY END USER, 2025-2035 (USD Billion)
    78. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.27.1 BY DEVICE, 2025-2035 (USD Billion)
    80. | | 7.27.2 BY END USER, 2025-2035 (USD Billion)
    81. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.28.1 BY DEVICE, 2025-2035 (USD Billion)
    83. | | 7.28.2 BY END USER, 2025-2035 (USD Billion)
    84. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    85. | | 7.29.1 BY DEVICE, 2025-2035 (USD Billion)
    86. | | 7.29.2 BY END USER, 2025-2035 (USD Billion)
    87. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.30.1 BY DEVICE, 2025-2035 (USD Billion)
    89. | | 7.30.2 BY END USER, 2025-2035 (USD Billion)
    90. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    91. | | 7.31.1
    92. | 7.32 ACQUISITION/PARTNERSHIP
    93. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Device (USD Billion, 2025-2035)

  • Sphygmomanometer
  • Automated Blood Pressure Monitor
  • BP Transducers
  • Ambulatory Blood Pressure Monitor

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals & Clinics
  • Home Healthcare
  • Others
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions